A natural product from polygonum cuspidatum Sieb. et Zucc. promotes tat-dependent HIV latency reversal through triggering P-TEFb's release from 7SK snRNP

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Wang, Cong ^a   Yang, Shuiyuan ^a   Lu, Huasong ^a,b   You, Hongchao ^a   Ni, Man ^a   Shan, Wenjun ^a   Lin, Ting ^a   Gao, Xiang ^a   Chen, Haifeng ^a   Zhou, Qiang ^a,b   Xue, Yuhua ^a  

^a XIAMEN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 CHLOROPHENYL) 2,3,9 TRIMETHYL 6H THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE 6 ACETIC ACID TERT BUTYL ESTER; ENZYME ACTIVATOR; NATURAL PRODUCT; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROCYANIDIN C 13,3',3'' TRI O GALLATE; PROSTRATIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; (+)-JQ1 COMPOUND; AZEPINE DERIVATIVE; BIOLOGICAL PRODUCT; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; PHORBOL ESTER; PROANTHOCYANIDIN; TRIAZOLE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; JURKAT CELL LINE; NONHUMAN; POLYGONUM CUSPIDATUM; PROTEIN SECRETION; TRANSCRIPTION INITIATION; VIRUS LATENCY; VIRUS TRANSCRIPTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LONG TERMINAL REPEAT; METABOLISM; PHYSIOLOGY; TIME FACTOR;

AZEPINES; BIOLOGICAL PRODUCTS; CELL SURVIVAL; DRUG SYNERGISM; FALLOPIA JAPONICA; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; JURKAT CELLS; PHORBOL ESTERS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROANTHOCYANIDINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TERMINAL REPEAT SEQUENCES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRIAZOLES; VIRUS LATENCY;

EID: 84957108603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142739     Document Type: Article

References (35)

1. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Archives of internal medicine. 2006; 166(15):1632-41. doi: 10.1001/archinte.166.15.1632 PMID: 16908797.
2. Bedimo R. Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Current HIV/AIDS reports. 2008; 5(3):140-9. PMID: 18627663.
3. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. Journal of acquired immune deficiency syndromes. 2009; 50(5):499-505. doi: 10.1097/QAI.0b013e31819c291b PMID: 19223782.
4. Jones KA, Peterlin BM. Control of RNA initiation and elongation at the HIV-1 promoter. Annual review of biochemistry. 1994; 63:717-43. doi: 10.1146/annurev.bi.63.070194.003441 PMID: 7979253.
5. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009; 323(5919):1304-7. doi: 10.1126/science.1165706 PMID: 19265012.
6. Trono D, Van Lint C, Rouzioux C, Verdin E, Barre-Sinoussi F, Chun TW, et al. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science. 2010; 329 (5988):174-80. doi: 10.1126/science.1191047 PMID: 20616270.
7. Contreras X, Barboric M, Lenasi T, Peterlin BM. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS pathogens. 2007; 3(10):1459-69. doi: 10. 1371/journal.ppat.0030146 PMID: 17937499; PubMed Central PMCID: PMC2014796.
8. Williams SA, Chen LF, Kwon H, Fenard D, Bisgrove D, Verdin E, et al. Prostratin antagonizes HIV latency by activating NF-kappaB. The Journal of biological chemistry. 2004; 279(40):42008-17. doi: 10.1074/jbc.M402124200 PMID: 15284245.
9. Edelstein LC, Micheva-Viteva S, Phelan BD, Dougherty JP. Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS research and human retroviruses. 2009; 25(9):883-7. doi: 10.1089/aid.2008.0294 PMID: 19689202; PubMed Central PMCID: PMC2828260.
10. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, et al. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Molecular and cellular biology. 2000; 20(14):5077-86. PMID: 10866664; PubMed Central PMCID: PMC85957.
11. Lu H, Li Z, Xue Y, Zhou Q. Viral-host interactions that control HIV-1 transcriptional elongation. Chemical reviews. 2013; 113(11):8567-82. doi: 10.1021/cr400120z PMID: 23795863; PubMed Central PMCID: PMC4310557.
12. Ping YH, Rana TM. Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes. The Journal of biological chemistry. 1999; 274(11):7399-404. PMID: 10066804.
13. Muniz L, Egloff S, Ughy B, Jady BE, Kiss T. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat. PLoS pathogens. 2010; 6(10):e1001152. doi: 10.1371/journal.ppat.1001152 PMID: 20976203; PubMed Central PMCID: PMC2954905.
14. Yik JH, Chen R, Pezda AC, Zhou Q. Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription. The Journal of biological chemistry. 2005; 280(16):16368-76. doi: 10.1074/jbc. M500912200 PMID: 15713661.
15. Nguyen VT, Kiss T, Michels AA, Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature. 2001; 414(6861):322-5. doi: 10.1038/35104581 PMID: 11713533.
16. Dulac C, Michels AA, Fraldi A, Bonnet F, Nguyen VT, Napolitano G, et al. Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer. The Journal of biological chemistry. 2005; 280(34):30619-29. doi: 10.1074/jbc.M502471200 PMID: 15994294.
17. Lu H, Li Z, Xue Y, Schulze-Gahmen U, Johnson JR, Krogan NJ, et al. AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(1): E15-24. doi: 10.1073/pnas.1318503111 PMID: 24367103; PubMed Central PMCID: PMC3890890.
18. He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A, et al. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Molecular cell. 2010; 38(3):428-38. doi: 10.1016/j.molcel.2010.04.013 PMID: 20471948; PubMed Central PMCID: PMC3085314.
19. Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Molecular cell. 2010; 38(3):439-51. doi: 10.1016/j.molcel.2010.04.012 PMID: 20471949; PubMed Central PMCID: PMC3595998.
20. Zhou Q, Li T, Price DH. RNA polymerase II elongation control. Annual review of biochemistry. 2012; 81:119-43. doi: 10.1146/annurev-biochem-052610-095910 PMID: 22404626; PubMed Central PMCID: PMC4273853.
21. Ott M, Geyer M, Zhou Q. The control of HIV transcription: keeping RNA polymerase II on track. Cell host & microbe. 2011; 10(5):426-35. doi: 10.1016/j.chom.2011.11.002 PMID: 22100159; PubMed Central PMCID: PMC3478145.
22. Peng W, Qin R, Li X, Zhou H. Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: a review. Journal of ethnopharmacology. 2013; 148(3):729-45. doi: 10.1016/j.jep.2013.05.007 PMID: 23707210.
23. Han JH, Koh W, Lee HJ, Lee HJ, Lee EO, Lee SJ, et al. Analgesic and anti-inflammatory effects of ethyl acetate fraction of Polygonum cuspidatum in experimental animals. Immunopharmacology and immunotoxicology. 2012; 34(2):191-5. doi: 10.3109/08923973.2011.590499 PMID: 21711083.
24. Editorial Committee of Chinese Pharmacopoeia. Chinese Pharmacopoeia. ( Medical Science and Technology Press: Beijing, China):194-5.
25. Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. The EMBO journal. 2003; 22(8):1868-77. doi: 10.1093/emboj/cdg188 PMID: 12682019; PubMed Central PMCID: PMC154479.
26. DelphineCallemien SC. Use of Rp-hplc-esi (-)-ms/ms to Differentiate Various Proanthocyanidin Isomers in Lager Beer Extracts. J Am Soc Brew Chem. 2008; 66(2):109-15.
27. Kashiwada Y, Nonaka G, Nishioka I. Tannins and related compounds. XLVIII. Rhubarb. (7). Isolation and characterization of new dimeric and trimeric procyanidins. Chemical & pharmaceutical bulletin. 1986; 34(10):4083-91. PMID: 3829147.
28. Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, et al. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. Journal of virology. 2008; 82 (24):12291-303. doi: 10.1128/JVI.01383-08 PMID: 18829756; PubMed Central PMCID: PMC2593349.
29. Li Z, Guo J, Wu Y, Zhou Q. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic acids research. 2013; 41(1):277-87. doi: 10.1093/nar/gks976 PMID: 23087374; PubMed Central PMCID: PMC3592394.
30. Zhu J, Gaiha GD, John SP, Pertel T, Chin CR, Gao G, et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell reports. 2012; 2(4):807-16. doi: 10.1016/j.celrep.2012.09.008 PMID: 23041316; PubMed Central PMCID: PMC3523124.
31. Marsden MD, Zack JA. Eradication of HIV: current challenges and new directions. The Journal of antimicrobial chemotherapy. 2009; 63(1):7-10. doi: 10.1093/jac/dkn455 PMID: 18984648; PubMed Central PMCID: PMC2721701.
32. Mohammadi P, di Iulio J, Munoz M, Martinez R, Bartha I, Cavassini M, et al. Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. PLoS pathogens. 2014; 10(5):e1004156. doi: 10. 1371/journal.ppat.1004156 PMID: 24875931; PubMed Central PMCID: PMC4038609.
33. Laird GM, Bullen CK, Rosenbloom DI, Martin AR, Hill AL, Durand CM, et al. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. The Journal of clinical investigation. 2015; 125 (5):1901-12. doi: 10.1172/JCI80142 PMID: 25822022; PubMed Central PMCID: PMC4463209.
34. Chen R, Liu M, Li H, Xue Y, Ramey WN, He N, et al. PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling. Genes & development. 2008; 22(10):1356-68. doi: 10.1101/gad.1636008 PMID: 18483222; PubMed Central PMCID: PMC2377190.
35. He N, Pezda AC, Zhou Q. Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. Molecular and cellular biology. 2006; 26(19):7068-76. doi: 10.1128/MCB. 00778-06 PMID: 16980611; PubMed Central PMCID: PMC1592901.